SOURCE: Equities Awareness Group

December 17, 2012 09:00 ET

Equities Awareness Group LLC Initiates Coverage on VolitionRX Ltd. (OTCQB: VNRX)

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Equities Awareness Group LLC

NEW YORK, NY--(Marketwire - Dec 17, 2012) - Equities Awareness Group LLC is pleased to announce that they have been attained for marketing and awareness services by VolitionRX Ltd. (OTCQB: VNRX). Vice President of Equities Awareness Group, Michael Perinotti, stated, "We are pleased to be working with such a great and promising company in the cancer diagnosis space. VolitionRX Ltd.'s goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests. Their technology is truly an industry breakthrough and we look forward to sharing their progress with the investment community."

VolitionRX Ltd. (OTCQB: VNRX) is led by Cameron Reynolds, President and CEO. Mr. Reynolds is aiming to address the need for inexpensive, accurate, and scalable cancer diagnostics with its NuQ® suite of products. NuQ® is based on proprietary Nucleosomics® technology: measurement and identification of nucleosome structures in the blood. Their products have strong IP protection with patent applications in Europe, USA, and worldwide.

Volition (OTCQB: VNRX) is currently undergoing clinical trials for their products. Following clinical trials and regulatory approval, Volition will offer tests for individual cancers under the NuQ® brand.

Volition is also developing HyperGenomics®, a technology that aims to determine specific epigenetic signatures from cancer biopsies by reading "hypersensitive sites" along the DNA string. These tests are being developed as a second line once cancer has been diagnosed, to accurately determine the specific subtype of disease and to help decide the most appropriate therapy.

About Equities Awareness Group LLC

Equities Awareness Group, LLC (EAG) represents a new breed in financial marketing and advisory agency that specializes in assisting the underserved small and micro-cap communities. EAG was formed as the first fully integrated media agency exclusively focused on equities.

EAG is a financial communications agency that incorporates three key disciplines into every client relationship: public relations, investor relations and brand marketing. For companies of all sizes, our talented and tested team delivers cost-effective strategy, tenacious execution and an ever-expanding body of digital and traditional marketing & communications expertise.

At EAG we understand that the value of a company in the marketplace is greatly determined by its corporate image, along with its ability to create and maintain an informed investor audience and thus prepare our clients for all the situations that being a public company has to offer. EAG will be successful based on how proficient, creative and responsive we are to our clients' needs. As a boutique firm, we strive to maintain our strong reputation, exceed expectations and perform to the best of our ability. We accept nothing less than absolute excellence and adhere to the highest principles and standards.

Disclosure: Equities Awareness Group LLC is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Equities Awareness Group LLC has been compensated twenty thousand dollars for marketing awareness on VolitionRX Ltd. and expects to receive more on an ongoing monthly basis. Please read our report and visit our website, for complete risks and disclosures.

Contact Information